ABCC3 and central nervous system cancer: ABCC3 presents lower expression levels in normal brain than in glioblastoma samples (Fig. 1f, and Supplementary Fig. S3), and its expression increases with glioma tumor grade (Figs. 1g, and Supplementary Fig. S1b,e).